TLR9 drives the development of transitional B cells towards the marginal zone pathway and promotes autoimmunity

Journal of Autoimmunity

Volumn 39, Issue 3, 2012, Pages 173-179

  Guerrier, Thomas ^a   Youinou, Pierre ^a,b   Pers, Jacques Olivier ^a,b   Jamin, Christophe ^a,b  

^a UNIVERSITÉ EUROPÉENNE DE BRETAGNE   (France)

^b BREST UNIVERSITY HOSPITAL   (France)

Author keywords

Autoreactivity; B lymphocytes; Marginal zone; Toll like receptor

Indexed keywords

CD23 ANTIGEN; CD24 ANTIGEN; CD38 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; IMMUNOGLOBULIN D; IMMUNOGLOBULIN M; NOTCH2 RECEPTOR; TOLL LIKE RECEPTOR 9;

ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; GERMINAL CENTER; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PHENOTYPE; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADJUVANTS, IMMUNOLOGIC; ANTIBODY-PRODUCING CELLS; ANTIGENS, CD; AUTOANTIBODIES; AUTOIMMUNITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL BLOOD; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE ACTIVATION; OLIGODEOXYRIBONUCLEOTIDES; PALATINE TONSIL; PRECURSOR CELLS, B-LYMPHOID; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 9;

EID: 84865400741     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2012.05.012     Document Type: Article

References (61)

1. Burnet F.M. A modification of Jerne's theory of antibody production using the concept of clonal selection. CA Cancer J Clin 1976, 26:119-121.
2. Hillion S., Rochas C., Youinou P., Jamin C. Expression and reexpression of recombination activating genes: relevance to the development of autoimmune states. Ann N Y Acad Sci 2005, 1050:10-18.
3. Tsubata T., Reth M. The products of pre-B cell-specific genes (lambda 5 and VpreB) and the immunoglobulin mu chain form a complex that is transported onto the cell surface. J Exp Med 1990, 172:973-976.
4. Gauthier L., Rossi B., Roux F., Termine E., Schiff C. Galectin-1 is a stromal cell ligand of the pre-B cell receptor (BCR) implicated in synapse formation between pre-B and stromal cells and in pre-BCR triggering. Proc Natl Acad Sci U S A 2002, 99:13014-13019.
5. Nemazee D. Receptor editing in lymphocyte development and central tolerance. Nat Rev Immunol 2006, 6:728-740.
6. Hillion S., Rochas C., Devauchelle V., Youinou P., Jamin C. Central and peripheral RAG protein re-expression: underestimate mechanisms of tolerance?. Scand J Immunol 2006, 64:185-189.
7. Wardemann H., Yurasov S., Schaefer A., Young J.W., Meffre E., Nussenzweig M.C. Predominant autoantibody production by early human B cell precursors. Science 2003, 301:1374-1377.
8. Le Pottier L., Devauchelle V., Pers J.O., Jamin C., Youinou P. The mosaic of B-cell subsets (with special emphasis on primary Sjogren's syndrome). Autoimmun Rev 2007, 6:149-154.
9. Youinou P., Jamin C., Lydyard P.M. CD5 expression in human B-cell populations. Immunol Today 1999, 20:312-316.
10. Hillion S., Saraux A., Youinou P., Jamin C. Expression of RAGs in peripheral B cells outside germinal centers is associated with the expression of CD5. J Immunol 2005, 174:5553-5561.
11. Hillion S., Dueymes M., Youinou P., Jamin C. IL-6 contributes to the expression of RAGs in human mature B cells. J Immunol 2007, 179:6790-6798.
12. Hillion S., Youinou P., Jamin C. Peripheral expression of RAG in human B lymphocytes in normal and pathological conditions is dependent on interleukin-6. Autoimmun Rev 2007, 6:415-420.
13. Lesley R., Xu Y., Kalled S.L., Hess D.M., Schwab S.R., Shu H.B., et al. Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. Immunity 2004, 20:441-453.
14. Herve M., Isnardi I., Ng Y.S., Bussel J.B., Ochs H.D., Cunningham-Rundles C., et al. CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance. J Exp Med 2007, 204:1583-1593.
15. Pillai S., Cariappa A., Moran S.T. Marginal zone B cells. Annu Rev Immunol 2005, 23:161-196.
16. Martin F., Kearney J.F. Marginal-zone B cells. Nat Rev Immunol 2002, 2:323-335.
17. Carsetti R., Rosado M.M., Wardmann H. Peripheral development of B cells in mouse and man. Immunol Rev 2004, 197:179-191.
18. Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 2006, 6:823-835.
19. Isnardi I., Ng Y.S., Srdanovic I., Motaghedi R., Rudchenko S., von Bernuth H., et al. IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans. Immunity 2008, 29:746-757.
20. Capolunghi F., Cascioli S., Giorda E., Rosado M.M., Plebani A., Auriti C., et al. CpG drives human transitional B cells to terminal differentiation and production of natural antibodies. J Immunol 2008, 180:800-808.
21. Huggins J., Pellegrin T., Felgar R.E., Wei C., Brown M., Zheng B., et al. CpG DNA activation and plasma-cell differentiation of CD27- naive human B cells. Blood 2007, 109:1611-1619.
22. He B., Qiao X., Cerutti A. CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10. J Immunol 2004, 173:4479-4491.
23. Poeck H., Wagner M., Battiany J., Rothenfusser S., Wellisch D., Hornung V., et al. Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help. Blood 2004, 103:3058-3064.
24. Bernasconi N.L., Traggiai E., Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002, 298:2199-2202.
25. Groom J., Kalled S.L., Cutler A.H., Olson C., Woodcock S.A., Schneider P., et al. Association of BAFF/BLyS over expression and altered B cell differentiation with Sjogren's syndrome. J Clin Invest 2002, 109:59-68.
26. Harris N.L. Lymphoid proliferations of the salivary glands. Am J Clin Pathol 1999, 111:S94-103.
27. Daridon C., Pers J.O., Devauchelle V., Martins-Carvalho C., Hutin P., Pennec Y.L., et al. Identification of transitional type II B cells in the salivary glands of patients with Sjogren's syndrome. Arthritis Rheum 2006, 54:2280-2288.
28. Guerrier T., Le Pottier L., Devauchelle V., Pers J.O., Jamin C., Youinou P. Role of toll-like receptors in primary Sjogren's syndrome with a special emphasis on B-cell maturation within exocrine tissues. J Autoimmun 2012, 39:69-76.
29. Le Pottier L., Devauchelle V., Fautrel A., Daridon C., Saraux A., Youinou P., et al. Ectopic germinal centers are rare in Sjogren's syndrome salivary glands and do not exclude autoreactive B cells. J Immunol 2009, 182:3540-3547.
30. Pugh-Bernard A.E., Silverman G.J., Cappione A.J., Villano M.E., Ryan D.H., Insel R.A., et al. Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance. J Clin Invest 2001, 108:1061-1070.
31. Cappione A., Anolik J.H., Pugh-Bernard A., Barnard J., Dutcher P., Silverman G., et al. Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. J Clin Invest 2005, 115:3205-3216.
32. Mageed R.A., MacKenzie L.E., Stevenson F.K., Yuksel B., Shokri F., Maziak B.R., et al. Selective expression of a VHIV subfamily of immunoglobulin genes in human CD5+ B lymphocytes from cord blood. J Exp Med 1991, 174:109-113.
33. Deane M., Mackenzie L.E., Stevenson F.K., Youinou P.Y., Lydyard P.M., Mageed R.A. The genetic basis of human VH4 gene family-associated cross-reactive idiotype expression in CD5+ and CD5- cord blood B-lymphocyte clones. Scand J Immunol 1993, 38:348-358.
34. Palanichamy A., Barnard J., Zheng B., Owen T., Quach T., Wei C., et al. Novel human transitional B cell populations revealed by B cell depletion therapy. J Immunol 2009, 182:5982-5993.
35. Sims G.P., Ettinger R., Shirota Y., Yarboro C.H., Illei G.G., Lipsky P.E. Identification and characterization of circulating human transitional B cells. Blood 2005, 105:4390-4398.
36. Gantner F., Hermann P., Nakashima K., Matsukawa S., Sakai K., Bacon K.B. CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides. Eur J Immunol 2003, 33:1576-1585.
37. Bernasconi N.L., Onai N., Lanzavecchia A. A role for toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood 2003, 101:4500-4504.
38. Papadimitraki E.D., Choulaki C., Koutala E., Bertsias G., Tsatsanis C., Gergianaki I., et al. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process. Arthritis Rheum 2006, 54:3601-3611.
39. Bekeredjian-Ding I.B., Wagner M., Hornung V., Giese T., Schnurr M., Endres S., et al. Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN. J Immunol 2005, 174:4043-4050.
40. Bekeredjian-Ding I., Inamura S., Giese T., Moll H., Endres S., Sing A., et al. Staphylococcus aureus protein A triggers T cell-independent B cell proliferation by sensitizing B cells for TLR2 ligands. J Immunol 2007, 178:2803-2812.
41. Lanzavecchia A., Sallusto F. Toll-like receptors and innate immunity in B-cell activation and antibody responses. Curr Opin Immunol 2007, 19:268-274.
42. Bourke E., Bosisio D., Golay J., Polentarutti N., Mantovani A. The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells. Blood 2003, 102:956-963.
43. Ueda Y., Liao D., Yang K., Patel A., Kelsoe G. T-independent activation-induced cytidine deaminase expression, class-switch recombination, and antibody production by immature/transitional 1 B cells. J Immunol 2007, 178:3593-3601.
44. Zeng D., Lee M.K., Tung J., Brendolan A., Strober S. Cutting edge: a role for CD1 in the pathogenesis of lupus in NZB/NZW mice. J Immunol 2000, 164:5000-5004.
45. Nijnik A., Ferry H., Lewis G., Rapsomaniki E., Leung J.C., Daser A., et al. Spontaneous B cell hyperactivity in autoimmune-prone MRL mice. Int Immunol 2006, 18:1127-1137.
46. Teng Y., Takahashi Y., Yamada M., Kurosu T., Koyama T., Miura O., et al. IRF4 negatively regulates proliferation of germinal center B cell-derived Burkitt's lymphoma cell lines and induces differentiation toward plasma cells. Eur J Cell Biol 2007, 86:581-589.
47. Saito T., Chiba S., Ichikawa M., Kunisato A., Asai T., Shimizu K., et al. Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development. Immunity 2003, 18:675-685.
48. Genestier L., Taillardet M., Mondiere P., Gheit H., Bella C., Defrance T. TLR agonists selectively promote terminal plasma cell differentiation of B cell subsets specialized in thymus-independent responses. J Immunol 2007, 178:7779-7786.
49. von Bernuth H., Picard C., Jin Z., Pankla R., Xiao H., Ku C.L., et al. Pyogenic bacterial infections in humans with MyD88 deficiency. Science 2008, 321:691-696.
50. Ehlers M., Fukuyama H., McGaha T.L., Aderem A., Ravetch J.V. TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. J Exp Med 2006, 203:553-561.
51. Lartigue A., Courville P., Auquit I., Francois A., Arnoult C., Tron F., et al. Role of TLR9 in anti-nucleosome and anti-DNA antibody production in lpr mutation-induced murine lupus. J Immunol 2006, 177:1349-1354.
52. Christensen S.R., Shlomchik M.J. Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors. Semin Immunol 2007, 19:11-23.
53. Perl A. Emerging new pathways of pathogenesis and targets for treatment in systemic lupus erythematosus and Sjogren's syndrome. Curr Opin Rheumatol 2009, 21:443-447.
54. Seite J.F., Guerrier T., Cornec D., Jamin C., Youinou P., Hillion S. TLR9 responses of B cells are repressed by intravenous immunoglobulin through the recruitment of phosphatase. J Autoimmun 2011, 37:190-197.
55. Kaveri S.V., Lacroix-Desmazes S., Bayry J. The antiinflammatory IgG. N Engl J Med 2008, 359:307-309.
56. Moutsopoulos H.M. A lifetime in autoimmunity. J Autoimmun 2010, 35:171-175.
57. Miyagawa F., Gutermuth J., Zhang H., Katz S.I. The use of mouse models to better understand mechanisms of autoimmunity and tolerance. J Autoimmun 2010, 35:192-198.
58. Manoussakis M.N., Kapsogeorgou E.K. The role of intrinsic epithelial activation in the pathogenesis of Sjogren's syndrome. J Autoimmun 2010, 35:219-224.
59. Tsuda M., Torgerson T.R., Selmi C., Gambineri E., Carneiro-Sampaio M., Mannurita S.C., et al. The spectrum of autoantibodies in IPEX syndrome is broad and includes antimitochondrial autoantibodies. J Autoimmun 2010, 35:265-268.
60. Gershwin M.E., Shoenfeld Y. Chella David: a lifetime contribution in translational immunology. J Autoimmun 2011, 37:59-62.
61. Behrens M., Smart M., Luckey D., Luthra H., Taneja V. To B or not to B: role of B cells in pathogenesis of arthritis in HLA transgenic mice. J Autoimmun 2011, 37:95-103.